Thrivent Financial for Lutherans
SYRS

Thrivent Financial for Lutherans’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History

Thrivent Financial for Lutherans’s Portfolio SYRS Stock Details SYRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,124
Closed -$122K – 2585
2020
Q4 		$122K Buy
+1,124
New +$122K ﹤0.01% 2436